Patient classification
Abstract
Clinical patient tissue samples are classified according to the physiological status of cells present in the sample. In some embodiments of the invention, such cells are classified according to their ability to respond to therapeutic agents and treatments. In other embodiments, the cells or tissue samples are classified according to their status with respect to the activity of pathways of interest. The information thus derived is useful in prognosis and diagnosis, and can further be used develop surrogate markers for disease states, and to investigate the effect of genetic polymorphisms in the responsiveness and state of cells involved in disease.
Term
Term ended
Projected expiry passed 13 September 2022, 4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
42 members in 8 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 95274401 | United States of America | A | |
| 0229097 | United States of America | W |
Members42
| Document | Office | Kind | |
|---|---|---|---|
| CA2400989A1 | Canada | A1 | |
| WO0167103A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4007401A | Australia | A | |
| WO0167103A9 | World Intellectual Property Organization (WIPO) | A9 | |
| EP1269187A1 | European Patent Office (EPO) | A1 | |
| US2003017445A1 | United States of America | A1 | |
| WO03023573A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2003113807A1 | United States of America | A1 | |
| US2003138811A1 | United States of America | A1 | |
| JP2003527110A | Japan | A | |
| WO03023573A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US6656695B2 | United States of America | B2 | |
| WO2004022711A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003268457A1 | Australia | A1 | |
| AU2003268457A8 | Australia | A8 | |
| US2004063088A1 | United States of America | A1 | |
| WO2004022711A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US6763307B2 | United States of America | B2 | |
| EP1436617A2 | European Patent Office (EPO) | A2 | |
| US2004157269A1 | United States of America | A1 | |
| US2004219592A1 | United States of America | A1 | |
| WO2004022711A9 | World Intellectual Property Organization (WIPO) | A9 | |
| EP1269187A4 | European Patent Office (EPO) | A4 | |
| AU2001240074B2 | Australia | B2 | |
| US7266458B2 | United States of America | B2 | |
| US2008064041A1 | United States of America | A1 | |
| US2008064056A1 | United States of America | A1 | |
| US2008070271A1 | United States of America | A1 | |
| EP1436617A4 | European Patent Office (EPO) | A4 | |
| EP1436617B1 | European Patent Office (EPO) | B1 | |
| ATE486281T1This record | Austria | T1 | |
| DE60238132D1 | Germany | D1 | |
| US7908089B2 | United States of America | B2 | |
| US7912651B2 | United States of America | B2 | |
| EP1269187B1 | European Patent Office (EPO) | B1 | |
| ATE516497T1 | Austria | T1 | |
| EP1269187B8 | European Patent Office (EPO) | B8 | |
| JP4798921B2 | Japan | B2 | |
| US8467970B2 | United States of America | B2 | |
| US2013266967A1 | United States of America | A1 | |
| CA2400989C | Canada | C | |
| US10018621B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 2775804
Titles2
- German
- PATIENTENKLASSIFIZIERUNG
- English
- PATIENT CLASSIFICATION
Classification
- CPC, 14
- G01N33/5091
- G01N33/5005
- G01N33/5008
- G01N33/5011
- G01N33/5023
- G01N33/5041
- G01N33/6863
- G01N33/6866
- G01N33/6869
- G01N33/6872
- G16B5/00
- G16B40/00
- G16B45/00
- G16B40/30
- IPC, 2
- G01N33 50
- G01N33 68